Details for Patent: 8,236,773
✉ Email this page to a colleague
Which drugs does patent 8,236,773 protect, and when does it expire?
Patent 8,236,773 protects IZERVAY and is included in one NDA.
This patent has seventy patent family members in twenty-three countries.
Drugs Protected by US Patent 8,236,773
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Astellas | IZERVAY | avacincaptad pegol sodium | SOLUTION;INTRAVITREAL | 217225-001 | Aug 4, 2023 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | TREATMENT OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION BY ADMINISTERTING AVACINCAPTAD PEGOL TO THE EYE | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,236,773
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2006214437 | ⤷ Subscribe | |||
| Brazil | PI0607002 | ⤷ Subscribe | |||
| Canada | 2597889 | ⤷ Subscribe | |||
| Canada | 2897900 | ⤷ Subscribe | |||
| Canada | 2992874 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
